4.8 Article

Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria

Related references

Note: Only part of the references are listed.
Review Multidisciplinary Sciences

Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference

Laura J. Corbin et al.

NATURE COMMUNICATIONS (2018)

Article Urology & Nephrology

An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria

Abigail Liebow et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Article Multidisciplinary Sciences

Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity

Danish Saleheen et al.

NATURE (2017)

News Item Biotechnology & Applied Microbiology

Calls grow to tap the gold mine of human genetic knockouts

[Anonymous]

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Medicine, General & Internal

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9

Kevin Fitzgerald et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Biotechnology & Applied Microbiology

Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I

Cristina Martin-Higueras et al.

MOLECULAR THERAPY (2016)

Article Multidisciplinary Sciences

Health and population effects of rare gene knockouts in adult humans with related parents

Vagheesh M. Narasimhan et al.

SCIENCE (2016)

Article Genetics & Heredity

Mutations in HAO1 encoding glycolate oxidase cause isolated glycolic aciduria

Yaacov Frishberg et al.

JOURNAL OF MEDICAL GENETICS (2014)

Review Medicine, General & Internal

Primary Hyperoxaluria

Pierre Cochat et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Genetics & Heredity

Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote

Zhenze Zhao et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2006)